What is the recommended dosing and titration schedule for extended‑release amphetamine (Adderall XR) in adults and adolescents?

Extended-Release Amphetamine (Adderall XR) Dosing and Titration

For adults with ADHD, initiate Adderall XR at 20 mg once daily in the morning, then increase by 5–10 mg weekly based on symptom response and tolerability, with a standard maximum of 40 mg/day; doses up to 60–65 mg/day may be justified only when lower doses fail and higher doses produce no dose-limiting side effects. 1, 2

Starting Doses by Age Group

Adults (≥18 years)

• Begin with 20 mg once daily upon awakening as the FDA-approved starting dose for treatment-naïve adults or those switching from another medication. 1, 3
• When a lower initial dose is clinically appropriate, adults may start at 10 mg once daily, though 20 mg is the standard recommendation. 1

Adolescents (13–17 years)

• Initiate at 10 mg once daily in the morning for adolescents starting treatment or switching medications. 1, 4
• After one week, increase to 20 mg/day if ADHD symptoms remain inadequately controlled. 1

Children (6–12 years)

• Start with 10 mg once daily in the morning for children beginning treatment or transitioning from another medication. 1
• When clinical judgment supports a lower initial dose, begin with 5 mg once daily in the morning. 1
• The maximum recommended dose for children is 30 mg/day; doses exceeding 30 mg have not been studied in this age group. 1

Weekly Titration Protocol

• Increase the dose by 5–10 mg increments each week until optimal symptom control is achieved or dose-limiting adverse effects emerge. 5, 2
• Stimulants produce observable clinical improvement within days, allowing rapid assessment of efficacy at each dose level. 6
• Obtain weekly ADHD rating scales from patients (and teachers/parents for pediatric patients) during titration to objectively quantify symptom improvement. 5, 2
• Continue dose escalation until (a) optimal symptom control is achieved, (b) dose-limiting side effects appear, or (c) the maximum recommended dose is reached. 2

Maximum Dose Guidelines

Standard Maximum Doses

• The standard maximum is 40 mg/day for amphetamines, serving as the regulatory ceiling recommended by the American Academy of Child and Adolescent Psychiatry and FDA labeling. 5, 2, 1
• For children weighing <25 kg, single doses should not exceed 10 mg of amphetamine. 5, 2

When Higher Doses May Be Considered

• In adults, total daily doses of 60–65 mg can be justified only when: (1) symptoms remain uncontrolled at ≤40 mg, (2) the higher dose does not produce side effects such as weight loss, blood pressure elevation, or agitation, (3) there is documented failure of lower doses, and (4) the patient is closely monitored for tolerance. 2
• Adults may require higher total daily doses because longer functional days (work or evening responsibilities) necessitate more sustained symptom control throughout the day. 2
• If the 40 mg/day ceiling does not provide adequate symptom control, consider switching to methylphenidate (maximum 60 mg/day) or adding environmental/psychosocial interventions rather than further dose escalation. 5, 2

Administration Guidelines

• Administer once daily in the morning upon awakening to maximize daytime symptom coverage. 1
• Avoid afternoon doses because of the potential for insomnia. 1
• Adderall XR may be taken with or without food; food prolongs time to peak concentration (Tmax) by approximately 2.5 hours but does not affect overall absorption. 1
• Capsules may be swallowed whole or opened and sprinkled on applesauce; the sprinkled mixture should be consumed immediately without chewing, and the entire capsule contents must be taken (do not divide doses). 1

Baseline Assessment Before Initiation

• Perform a comprehensive physical examination including blood pressure, pulse, height, and weight before starting therapy. 5, 6
• Obtain a detailed cardiac history (syncope, chest pain, palpitations, exercise intolerance) and family history of premature cardiovascular death, arrhythmias, or structural heart disease. 6
• Document all prior ADHD treatments (medications, doses, duration, response, side effects, adherence). 5, 6
• Screen adolescents and adults for substance-use risk before prescribing stimulants. 6, 7

Ongoing Monitoring Requirements

During Titration

• Measure blood pressure and pulse at each dose adjustment to detect cardiovascular effects. 5, 6, 2
• Record height and weight at every visit (particularly critical in pediatric patients) to monitor appetite suppression and growth effects. 5, 6, 2
• Assess sleep quality and appetite changes at each follow-up, as these are the most common dose-limiting side effects. 6, 2

Maintenance Phase

• Adults: Check blood pressure and pulse quarterly during maintenance therapy. 5, 6
• Children/Adolescents: Perform annual vital-sign assessment and measure height and weight at every visit. 5, 6
• Monitor for tolerance development, which is rare but requires documentation when doses exceed standard limits. 2

Pharmacokinetic Considerations

• The time to peak concentration (Tmax) is approximately 7 hours for Adderall XR, about 4 hours longer than immediate-release formulations. 1
• Mean elimination half-life is 10 hours in adults, 11 hours in adolescents ≤75 kg, and 9 hours in children aged 6–12 years for d-amphetamine. 1
• Adderall XR demonstrates linear pharmacokinetics over the dose range of 20–60 mg in adults and adolescents >75 kg, 10–40 mg in adolescents ≤75 kg, and 5–30 mg in children aged 6–12 years. 1

Assessment Before Exceeding Standard Doses

• Verify medication adherence and confirm the patient takes the medication consistently and early enough each morning before considering dose escalation beyond 40 mg. 2
• Trial an alternative stimulant class (methylphenidate) before increasing amphetamine doses beyond 40 mg, as approximately 40% of patients show preferential response to one stimulant class over another. 6, 2

Common Pitfalls to Avoid

• Do not under-dose stimulants out of fear of side effects; systematic titration protocols enable approximately 70% of patients to achieve optimal response. 5, 6
• Do not calculate doses solely on mg/kg basis; systematic titration to optimal effect is more important than strict weight-based calculations, with 70% of patients responding optimally when proper titration protocols are followed. 5, 6
• Do not assume the current dose is adequate without systematic weekly symptom ratings; 54–70% of adults with ADHD respond to stimulants when properly titrated. 6
• Do not exceed 40 mg/day without documented justification that lower doses failed to control symptoms and higher doses are not causing additional adverse effects such as weight loss, blood pressure elevation, or agitation. 2

Expected Efficacy

• Stimulants achieve 70–80% response rates in adult ADHD when properly titrated, with the largest effect sizes (≈1.0) among all ADHD medication classes. 6, 3
• Approximately 90% of patients will respond to one of the psychostimulants if medications from both methylphenidate and amphetamine classes are tried. 5, 7
• Clinical trials demonstrate statistically and clinically significant ADHD symptom reduction across all doses (10–40 mg) in adolescents and adults, with improvements observable within the first treatment week. 4, 3